Literature DB >> 23092694

Antiepileptic drug effects on mood and behavior: molecular targets.

Piero Perucca1, Marco Mula.   

Abstract

With almost 100 years of clinical experience, antiepileptic drugs (AEDs) remain the mainstay of epilepsy treatment. They suppress epileptic seizures by acting on a variety of mechanisms and molecular targets involved in the regulation of neuronal excitability. These include inhibitory-GABAergic and excitatory-glutamatergic neurotransmission, as well as ion (sodium and calcium) conductance through voltage-gated channels. On the other hand, accruing evidence indicates that these mechanisms and targets are also implicated in the regulation of mood and behavior, which may explain why each AED is associated with specific psychotropic effects. These effects, however, cannot be explained solely on the basis of the known mode of action of each AED, and other mechanisms or targets are likely to be implicated. In this article, we review positive and negative effects of AEDs on mood and behavior, discuss putative underlying mechanisms, and highlight knowledge gaps which should be addressed in future studies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23092694     DOI: 10.1016/j.yebeh.2012.09.018

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  16 in total

1.  Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV.

Authors:  Kristin Marie Knudsen-Baas; Tom Børge Johannesen; Tor Åge Myklebust; Jan Harald Aarseth; Jone Furlund Owe; Nils Erik Gilhus; Anette Margrethe Storstein
Journal:  J Neurooncol       Date:  2018-11-23       Impact factor: 4.130

Review 2.  Epilepsy and Psychiatric Comorbidities: Drug Selection.

Authors:  Marco Mula
Journal:  Curr Treat Options Neurol       Date:  2017-10-19       Impact factor: 3.598

3.  [Rapid detection of a depressive disorder in persons with epilepsy. Validation of a German version of the NDDI-E].

Authors:  C Brandt; K Labudda; D Illies; M Schöndienst; T W May
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

4.  fosB-null mice display impaired adult hippocampal neurogenesis and spontaneous epilepsy with depressive behavior.

Authors:  Noriko Yutsudo; Takashi Kamada; Kosuke Kajitani; Hiroko Nomaru; Atsuhisa Katogi; Yoko H Ohnishi; Yoshinori N Ohnishi; Kei-ichiro Takase; Kunihiko Sakumi; Hiroshi Shigeto; Yusaku Nakabeppu
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

5.  Antiepileptic potential of matrine via regulation the levels of gamma-aminobutyric acid and glutamic acid in the brain.

Authors:  Jun Xiang; Yugang Jiang
Journal:  Int J Mol Sci       Date:  2013-12-05       Impact factor: 5.923

Review 6.  Depression and anxiety in people with epilepsy.

Authors:  Oh-Young Kwon; Sung-Pa Park
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

Review 7.  Psychosocial aspects of epilepsy: a wider approach.

Authors:  Marco Mula; Josemir W Sander
Journal:  BJPsych Open       Date:  2016-08-17

8.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Authors:  Paola Imbrici; Diana Conte Camerino; Domenico Tricarico
Journal:  Front Genet       Date:  2013-05-07       Impact factor: 4.599

9.  Obsessive-compulsive symptoms and their impacts on psychosocial functioning in people with epilepsy.

Authors:  Ji-Hye Seo; Won-Kee Lee; Sung-Pa Park
Journal:  J Clin Neurol       Date:  2014-04-23       Impact factor: 3.077

10.  Substituted N-(biphenyl-4'-yl)methyl (R)-2-acetamido-3-methoxypropionamides: potent anticonvulsants that affect frequency (use) dependence and slow inactivation of sodium channels.

Authors:  Hyosung Lee; Ki Duk Park; Robert Torregrosa; Xiao-Fang Yang; Erik T Dustrude; Yuying Wang; Sarah M Wilson; Cindy Barbosa; Yucheng Xiao; Theodore R Cummins; Rajesh Khanna; Harold Kohn
Journal:  J Med Chem       Date:  2014-07-15       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.